Literature DB >> 8897554

Urinary glycosaminoglycan excretion in healthy and stone-forming children.

F Harangi1, Z Györke, B Melegh.   

Abstract

Both in vivo and in vitro studies suggest that macromolecules excreted in the urine, e.g. glycosaminoglycans (GAGs) may be inhibitors of kidney stone formation. We evaluated urinary GAG excretion in 22 children with calcium oxalate stones [8 with absorptive hypercalciuria, 6 with renal hypercalciuria (RH), 8 with normocalciuria], and in 20 age-matched controls. There was no significant difference between the two groups in the total urinary GAG level. In terms of the various GAG fractions, patients with RH excreted considerably less keratan sulphate and considerably more dermatan sulphate than the other patients and healthy controls. There was no difference between the two groups in condroitin sulphate, heparan sulphate and hyaluronic acid excretion. We conclude that there is no significant correlation between the formation of calcium oxalate stones and urinary GAG excretion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8897554     DOI: 10.1007/s004670050159

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  28 in total

1.  Binding of glycosaminoglycan inhibitors to calcium oxalate crystals in relation to ionic strength.

Authors:  B Fellström; M Lindsjö; B G Danielson; F A Karlsson; S Ljunghall
Journal:  Clin Chim Acta       Date:  1989-04-14       Impact factor: 3.786

2.  Possible role for chondroitin sulfate in urolithiasis: in vivo studies in an experimental model.

Authors:  Y M Michelacci; M A Boim; C T Bergamaschi; R M Rovigatti; N Schor
Journal:  Clin Chim Acta       Date:  1992-06-15       Impact factor: 3.786

3.  Uric acid and its relationship with glycosaminoglycans in normal and stone-former subjects.

Authors:  A Conte; P Roca; C Genestar; F Grases
Journal:  Nephron       Date:  1989       Impact factor: 2.847

4.  Comparative study of the circadian rhythmicity in the urinary concentration of glycosaminoglycans in patients of calcium oxalate nephrolithiasis and in healthy adults.

Authors:  H Sidhu; S K Thind; R Nath; S Vaidyanathan; A K Hemal; A K Mandal; K Krishan
Journal:  Urol Int       Date:  1989       Impact factor: 2.089

5.  Surface interaction between glycosaminoglycans and calcium oxalate.

Authors:  A H Angell; M I Resnick
Journal:  J Urol       Date:  1989-05       Impact factor: 7.450

6.  A study of glycosaminoglycan excretion in normal and stone-forming subjects using a modified cetylpyridinium chloride technique.

Authors:  C T Samuell
Journal:  Clin Chim Acta       Date:  1981-11-25       Impact factor: 3.786

7.  Glycosaminoglycans, uric acid and calcium oxalate urolithiasis.

Authors:  F Grases; A Costa-Bauzá; J G March; L Masárová
Journal:  Urol Res       Date:  1991

8.  Urinary glycosaminoglycan excretion in normal and stone-forming subjects: significant disturbance in recurrent stone formers.

Authors:  M T Nikkilä
Journal:  Urol Int       Date:  1989       Impact factor: 2.089

9.  Matrix glycosaminoglycan in urinary stones.

Authors:  S Nishio; Y Abe; A Wakatsuki; H Iwata; K Ochi; M Takeuchi; A Matsumoto
Journal:  J Urol       Date:  1985-09       Impact factor: 7.450

10.  The excretion of glycosaminoglycans in the urine of calcium-oxalate-stone patients and healthy persons.

Authors:  A Hesse; H Wuzel; W Vahlensieck
Journal:  Urol Int       Date:  1986       Impact factor: 2.089

View more
  3 in total

Review 1.  Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.

Authors:  R L Ryall
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 2.  Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.

Authors:  R L Ryall
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

3.  Age-Specific Excretion of Calcium, Oxalate, Citrate, and Glycosaminoglycans and Their Ratios in Healthy Children and Children with Urolithiasis.

Authors:  Daniel Turudic; Anja Tea Golubic; Mila Lovric; Marko Bilic; Danko Milosevic
Journal:  Biomolecules       Date:  2021-05-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.